CLINICAL_TRIALS
trial_result
· 2011-06-22
Clinical Trial Update: Atomoxetine in the Treatment of Binge Eating Disorder [Phase 4]
Summary
A Phase 4 clinical trial evaluating atomoxetine for the treatment of binge eating disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lindner Center of HOPE | Conditions: Binge-eating Disorder | Phase 4 | Status: COMPLETED